These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 17952155)

  • 41. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer surveillance in inflammatory bowel disease: new molecular approaches.
    Risques RA; Rabinovitch PS; Brentnall TA
    Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Early detection of colorectal carcinoma. Pros and cons].
    von Betzler M
    MMW Fortschr Med; 2005 Apr; 147(14):26-8. PubMed ID: 15887679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of inflammatory bowel disease.
    Botoman VA; Bonner GF; Botoman DA
    Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Surveillance colonoscopy in ulcerative colitis patients in Germany].
    Kaltz B; Bokemeyer B; Hoffmann J; Porschen R; Rogler G; Schmiegel W
    Z Gastroenterol; 2007 Apr; 45(4):325-31. PubMed ID: 17427117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer and pediatric inflammatory bowel disease.
    Kayton ML
    Semin Pediatr Surg; 2007 Aug; 16(3):205-13. PubMed ID: 17602977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L; Sokol H; Seksik P
    Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysplasia in inflammatory bowel diseases.
    Mescoli C; Albertoni L; D'incá R; Rugge M
    Dig Liver Dis; 2013 Mar; 45(3):186-94. PubMed ID: 22974564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Association between membranous glomerulonephritis and Crohn's disease].
    Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
    Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer surveillance colonoscopy in ulcerative colitis: sense or nonsense?
    Schapiro M
    Schweiz Med Wochenschr Suppl; 1996; 79():5S-8S. PubMed ID: 8701261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal cancer in idiopathic inflammatory bowel disease.
    Harpaz N; Talbot IC
    Semin Diagn Pathol; 1996 Nov; 13(4):339-57. PubMed ID: 8946611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary complications in patients with inflammatory bowel disease.
    Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P
    Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?
    Giannini EG; Kane SV; Testa R; Savarino V
    Dig Liver Dis; 2005 Oct; 37(10):723-31. PubMed ID: 16023905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mesalazine in ulcerative colitis. Fewer cases of colorectal carcinoma].
    MMW Fortschr Med; 2002 Feb; 144(9):51. PubMed ID: 11921656
    [No Abstract]   [Full Text] [Related]  

  • 59. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years.
    Friedman S; Rubin PH; Bodian C; Harpaz N; Present DH
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):993-8; quiz 953-4. PubMed ID: 18585966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pregnancy and labor in ulcerative colitis and Crohn disease].
    Moum B
    Tidsskr Nor Laegeforen; 2001 Jan; 121(3):322-5. PubMed ID: 11242875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.